OUR MISSION

Developing treatments for the drug resistant world

 

OUR LEADERSHIP

Yosef Refaeli, Ph.D.

Chief Executive Officer

Co-Founder

Brian Turner, Ph.D.

President & Chief Scientific Officer

Co-Founder

James Kelly

Chief Financial Officer

Robert Gulock

Chief Commercial Officer